Succinct Healthcare Communications has entered a market access partnership with London-based cancer research and treatment centre The Royal Marsden (TRM) NHS Foundation Trust.
The project will focus on sharing knowledge between The Royal Marsden and the Amersham, UK communications agency, and learning about non-financial issues relating to new medicines and healthcare technologies.
The non-financial issues stem from an increasing emphasis on service delivery and patient pathways, and include logistical considerations, such as treatment location (hospital or community), clinic organisations/staffing and patient bed days, which can lead to delays in treatment.
The partnership will feature programmes, including:
- New medicines service delivery advice sheets – setting out the potential service impact of pipeline medicines 18-months before their anticipated marketing authorisation, available electronically for distribution nationwide
- Industry preceptorships – regular days for industry personnel to visit TRM and gain insight into the roles and responsibilities of staff
- Pharmacist training days – to help TRM pharmacists understand the roles and responsibilities of pharmaceutical industry personnel
“We are proud to have formed what we believe is a unique partnership between a medical education agency and an NHS organisation”, said Cathy Wright, director of succinct market access and value at Succinct.
“Through this working relationship with a world class cancer centre, we hope to further develop our expertise in market access and offer programmes that enhance communication and understanding between the pharmaceutical industry and healthcare providers.
“Our clients will benefit from our and TRM pharmacy expertise, providing the insight needed to develop both standard and bespoke market access initiatives,” she finished.